Insider filing · MRUS
A/s Genmab bought $79.1M of Merus (MRUS)
Executed Dec 22 2025, disclosed Dec 29 2025, 7 days later, against a two-business-day limit.
Value, as filed
$79.1M
815,444 sh across 4 lots
Executed
Dec 22 2025
the trade date, as filed
Disclosed
Dec 29 2025
7 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
AG
A/s Genmab
10% owner
profile →
A/s Genmab (10% owner) filed 4 Form 4 reports in the trailing twelve months (4 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in MRUS. The largest single filing was $102.4M of MRUS (1,055,784 sh across 2 lots, as filed), executed Dec 26 2025. The median gap between execution and disclosure was 4 days.
The name
MRUS
MRUS
MRUS · 10 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by A/s Genmab in MRUS
MRUSPURCHASE
Merus N.V.
$102.4M1,055,784 sh across 2 lots
Exec Dec 26 2025
Filed Dec 30 2025 · 5:41 PM ET MRUSPURCHASE Merus N.V. $27.0M
278,441 sh across 2 lots
Exec Dec 18 2025
Filed Dec 22 2025 · 5:15 PM ET MRUSPURCHASE Merus N.V. $26.3M
271,547 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:54 PM ET